Hidradenitis, Pyoderma Gangrenosum, Erythema Nodosum
USMLE Step 1 trap: Recommends debridement for pyoderma gangrenosum, ignoring pathergy and the need for immunosuppression. Pyoderma gangrenosum exhibits pathergy (worsening with trauma/debridement) and is treated with immunosuppression, not surgical debridement.
These three conditions — hidradenitis suppurativa (HS), pyoderma gangrenosum (PG), and erythema nodosum (EN) — are grouped together because they're all inflammatory skin/subcutaneous conditions with neutrophilic involvement and strong systemic associations. USMLE Step 1 tests them mostly through clinical vignettes where you have to recognize the condition from its distribution, lesion morphology, or associated disease. The tricky part is that all three can appear in patients with IBD, so the stem might make you think about the gut first and then ask about the skin finding. Don't get thrown off — treat each condition's features as its own distinct fingerprint.
The exam hits each one from a specific angle. For HS, it's about location (apocrine areas: axillae, groin, inframammary) and pathogenesis (follicular occlusion, not gland infection). For PG, the key trap is management — students see a necrotic ulcer and want to debride it, but that's exactly wrong because of pathergy. For EN, it's about locking in the pretibial location and recognizing it as septal panniculitis triggered by something systemic (sarcoidosis, strep, TB, OCP, IBD). USMLE Step 1 loves asking what to work up next after diagnosing EN.
What makes these tricky is that they look scarier than they are conceptually. Students over-medicalize HS by assuming it's eccrine gland disease (it's not — eccrine glands make sweat everywhere; apocrine glands are in the skin folds), and they misplace EN lesions onto the thighs or arms instead of the anterior shins. Nail the classic presentations and the one management pearl for PG, and you're covered for Step 1 purposes.
Common misconceptions
What the exam tests
- Know the classic distribution of hidradenitis suppurativa (axillae, groin, inframammary folds), its risk factors (obesity, smoking, female sex), and first-line treatments (topical clindamycin, oral antibiotics, adalimumab for severe disease) — the exam will test whether you understand it as a follicular occlusion disease in apocrine-bearing areas, not a primary gland infection.
- Recognize pyoderma gangrenosum by its necrotic, violaceous-bordered ulcer, its systemic associations (IBD, RA, hematologic malignancy), and critically its pathergy — trauma or debridement worsens the wound, so treatment is immunosuppression (steroids, cyclosporine), not surgery.
- Identify erythema nodosum by its tender, raised, erythematous nodules on the anterior shins (pretibial), understand its histopathology (septal panniculitis — inflammation of subcutaneous fat septa), and know the triggers that should prompt workup (strep, sarcoidosis, TB, IBD, oral contraceptives, coccidioidomycosis).
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →